Reuters logo
Spain's Grifols reports fivefold increase in 2012 profit
February 28, 2013 / 7:41 AM / in 5 years

Spain's Grifols reports fivefold increase in 2012 profit

MADRID, Feb 28 (Reuters) - Spanish pharmaceutical company Grifols reported a more than fivefold rise in full-year profit for 2012 to 257 million euros ($336.90 million), buoyed by its acquisition of U.S. firm Talecris last June and its wide geographic presence outside its depressed home market.

Barcelona-based Grifols said sales grew 46 percent year-on-year to reach 2.6 billion euros, in line with analyst expectations. ($1 = 0.7628 euros) (Reporting By Sonya Dowsett; Editing by Clare Kane)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below